Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis

BMC Primary Care

Table 2 Association Between Prescriber and Patient Characteristics with Only One Data Point and Warfarin Use

Not Associated with Warfarin Use	Associated with Increased Warfarin Use	Associated with Decreased Warfarin Use
Married	Vascular malformation	Fractures
Education	Hyperlipidemia	Albumin ≤ 30 g/L
Vascular aneurysm or arteriovenous malformation	Body mass index per 5 kg/m² increase	Anemia
Prosthetic valve	Heart rate per 10 beats per minute increase	Chronic obstructive pulmonary disease or asthma
Mitral stenosis	Male subject without prior cerebral vascular accident	Limited activities of daily living before admission
Valvular disease	Beta-blocker use
Rheumatic heart disease	Angiotensin-converting enzyme inhibitor use
Larger left atrial dimension	Diuretic use
History of atrial thrombus	Warfarin use upon admission
Terminal illness	Access to clinic with anticoagulation management services
Recent major surgery	Number of hospital beds, per 100 bed increase
Male subject with prior cerebral vascular accident	Location of diagnosis (hospital)
Digoxin use	Another indication for warfarin use
Nonsteroidal antiinflammatory use
Coagulopathy or thrombocytopenia
Access to medical care
Inpatient status
Treatment at a community hospital
Physicians' experience with warfarin

ISSN: 2731-4553